Your browser doesn't support javascript.
loading
Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial.
Mac Grory, Brian; Piccini, Jonathan P; Yaghi, Shadi; Poli, Sven; De Havenon, Adam; Rostanski, Sara K; Weiss, Martin; Xian, Ying; Johnston, S Claiborne; Feng, Wuwei.
  • Mac Grory B; Department of Neurology Duke University School of Medicine Durham NC.
  • Piccini JP; Division of Cardiology Department of Medicine Duke University School of Medicine Durham NC.
  • Yaghi S; Duke Clinical Research Institute Durham NC.
  • Poli S; Department of Neurology Warren Alpert Medical School of Brown University Providence RI.
  • De Havenon A; Department of Neurology & Stroke and Hertie Institute for Clinical Brain Research Eberhard Karls University Tübingen Tübingen Germany.
  • Rostanski SK; Department of Neurology Yale University School of Medicine New Haven CT.
  • Weiss M; Department of Neurology NYU Grossman School of Medicine New York NY.
  • Xian Y; Department of Neurology Duke University School of Medicine Durham NC.
  • Johnston SC; Department of Neurology Duke University School of Medicine Durham NC.
  • Feng W; Duke Clinical Research Institute Durham NC.
J Am Heart Assoc ; 11(3): e023223, 2022 02.
Article en En | MEDLINE | ID: mdl-35043692

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico / Hiperglucemia Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico / Hiperglucemia Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article